Analysts' New Coverage for May 15th (ACOR, AER, AL, AXR, BSQ

Analysts’ new coverage for Monday, May 15th: StockNews.com initiated coverage on shares of Acorda Therapeutics (NASDAQ:ACOR). The firm issued a buy rating on the stock. Citigroup Inc. initiated coverage on shares of AerCap (NYSE:AER). The firm issued a buy rating and a $71.00 price target on the stock. Citigroup Inc. initiated coverage on shares of […]

Related Keywords

Switzerland , Canada , , Switzerland Group , Liqtech International , Royal Bank , Healthcare Trust , Global Indemnity Group , Oppenheimer Holdings Inc , Elixirr International , China Yuchai International , Titan Pharmaceuticals , Factset Research Systems , Novabay Pharmaceuticals , Mexco Energy , Citigroup Inc , Marin Software , Origin Enterprises , Canaccord Genuity Group Inc , News Ratings For Acorda Therapeutics Inc Daily , Sigmatron International , Acorda Therapeutics Inc , Acorda Therapeutics , Air Lease , Diversified Healthcare Trust , Milestone Scientific , Navidea Biopharmaceuticals , Genuity Group , Odyssey Marine Exploration , Oncternal Therapeutics , Pretium Resources , Oppenheimer Holdings , World Wrestling Entertainment , Acorda Therapeutics Inc Daily , Aercap Holdings , Air Lease Co , Amrep Co , Bsquare Co , Clearone Inc , Cps Technologies Co , China Yuchai International Limited , Elixirr International Plc ,